Functional Technologies Corp.
TSX VENTURE : FEB

Functional Technologies Corp.

July 15, 2009 18:29 ET

Functional Technologies Reports Grant of Stock Options

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 15, 2009) - Functional Technologies Corp. (TSX VENTURE:FEB) reports the grant of stock options entitling the holders to purchase, for a period of five years, a total of 3,157,500 common shares at a price of $0.50 per share. These stock options will not be exercisable until the company has received approval of its shareholders and the TSX Venture Exchange to the company's amended stock option plan.

About Functional Technologies Corp.

Functional Technologies is a functional foods and biological health products company that develops and commercializes advanced yeast products, and other novel biological products, for the food and the health care industries. The company is currently commercializing a platform yeast technology that substantially reduces the formation of ethyl carbamate (also known as urethane, which has been recently reclassified by the World Health Organization up to a Group 2A carcinogen - the same carcinogen class as lead, mercury, acrylamide and diesel exhaust), from wines and other widely consumed fermented beverages and foods. As part of its core focus of improving and enhancing the quality of the global food and beverage supply, Functional Technologies has recently expanded its yeast portfolio through the licensing of proprietary hydrogen sulfide (H2S) reducing technology from the University of California at Davis. H2S is one of the most common occurring sensory defects, and a widespread problem, in wine production. In addition Functional Technologies, through its wholly-owned subsidiary Phyterra Bio Inc., is developing a platform of proprietary biological products, for animal health, utilizing proprietary science in the field of micro-algae.

For further company information, please access our website at www.functionaltechcorp.com.

Contact Information